Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Virtual Screening Techniques in Drug Discovery: Review and Recent Applications
Sheisi Fonseca Leite da Silva Rocha, Carolina G. Olanda, Harold Hilarion Fokoue, et al.
Current Topics in Medicinal Chemistry (2019) Vol. 19, Iss. 19, pp. 1751-1767
Closed Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations
Hind Yassmine Chennai, Salah Belaıdı, Lotfi Bourougaa, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1232-1232
Open Access | Times Cited: 9
Artificial intelligence and big data facilitated targeted drug discovery
Benquan Liu, Huiqin He, Hongyi Luo, et al.
Stroke and Vascular Neurology (2019) Vol. 4, Iss. 4, pp. 206-213
Open Access | Times Cited: 64
Beware of the generic machine learning-based scoring functions in structure-based virtual screening
Chao Shen, Ye Hu, Zhe Wang, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 60
Direct Keap1-kelch inhibitors as potential drug candidates for oxidative stress-orchestrated diseases: A review on In silico perspective
Ibrahim Damilare Boyenle, Ukachi Chiamaka Divine, Rofiat Adeyemi, et al.
Pharmacological Research (2021) Vol. 167, pp. 105577-105577
Closed Access | Times Cited: 44
Viral proteases as therapeutic targets
Taťána Majerová, Jan Konvalinka
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101159-101159
Open Access | Times Cited: 34
Design and Development of Novel Nutraceuticals: Current Trends and Methodologies
Thalia Tsiaka, Eftichia Kritsi, Konstantinos Tsiantas, et al.
Nutraceuticals (2022) Vol. 2, Iss. 2, pp. 71-90
Open Access | Times Cited: 28
Drug discovery by targeting the protein–protein interactions involved in autophagy
Honggang Xiang, Mi Zhou, Yan Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4373-4390
Open Access | Times Cited: 16
Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification
Ying Wang, Xiaomei He, Chunshi Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 193, pp. 112235-112235
Closed Access | Times Cited: 40
Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie, Shama Khan, Zehra, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2157-2157
Open Access | Times Cited: 36
Accuracy or novelty: what can we gain from target-specific machine-learning-based scoring functions in virtual screening?
Chao Shen, Gaoqi Weng, Xujun Zhang, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Closed Access | Times Cited: 34
Evaluation on the antiviral activity of aloe emodin against Micropterus salmoides rhabdovirus in vitro and in vivo
Yao Wang, Mengmeng Wang, Zhiyang Lin, et al.
Aquaculture (2025), pp. 742265-742265
Closed Access
Virtual Screening of Potential Inhibitors against the Penicillin-Binding Protein 1a (PBP1a) of Streptococcus pneumoniae
Adnan Shehzad, Farkhanda, Shah Zainab, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 3, pp. 181-185
Closed Access
Molecular Docking and Molecular Dynamics Aided Virtual Search of OliveNet™ Directory for Secoiridoids to Combat SARS-CoV-2 Infection and Associated Hyperinflammatory Responses
Neelaveni Thangavel, Mohammad Al Bratty, Hassan Ahmad Al Hazmi, et al.
Frontiers in Molecular Biosciences (2021) Vol. 7
Open Access | Times Cited: 31
Computer-aided drug design in seeking viral capsid modulators
Shujie Zhao, Xujie Zhang, Edeildo Ferreira da Silva‐Júnior, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103581-103581
Closed Access | Times Cited: 11
Optimization of virtual screening against phosphoinositide 3-kinase delta: Integration of common feature pharmacophore and multicomplex-based molecular docking
Jingyu Zhu, Huiqin Meng, Xintong Li, et al.
Computational Biology and Chemistry (2024) Vol. 109, pp. 108011-108011
Closed Access | Times Cited: 4
A review of machine learning-based methods for predicting drug–target interactions
Weisong Shi, Hong Yang, Linhai Xie, et al.
Health Information Science and Systems (2024) Vol. 12, Iss. 1
Closed Access | Times Cited: 4
AutoDesigner - Core Design, a De Novo Design Algorithm for Chemical Scaffolds: Application to the Design and Synthesis of Novel Selective Wee1 Inhibitors
Pieter H. Bos, Fabio Ranalli, E. A. Flood, et al.
(2024)
Open Access | Times Cited: 4
wSDTNBI: a novel network-based inference method for virtual screening
Zengrui Wu, Hui Ma, Zehui Liu, et al.
Chemical Science (2021) Vol. 13, Iss. 4, pp. 1060-1079
Open Access | Times Cited: 24
Machine learning on ligand-residue interaction profiles to significantly improve binding affinity prediction
Beihong Ji, Xibing He, Jingchen Zhai, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 23
Improved drug–target interaction prediction with intermolecular graph transformer
Siyuan Liu, Yusong Wang, Yifan Deng, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 5
Open Access | Times Cited: 18
Computer-Aided Drug Design Boosts RAS Inhibitor Discovery
Ge Wang, Yuhao Bai, Jiarui Cui, et al.
Molecules (2022) Vol. 27, Iss. 17, pp. 5710-5710
Open Access | Times Cited: 16
Discovery, evaluation and mechanism study of WDR5-targeted small molecular inhibitors for neuroblastoma
Qilei Han, Xiang-lei Zhang, Pengxuan Ren, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 4, pp. 877-887
Closed Access | Times Cited: 16
Discovery of an OTUD3 inhibitor for the treatment of non-small cell lung cancer
Y Zhang, Tongde Du, Na Liu, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 6
Open Access | Times Cited: 9
Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
Yuwei Wang, Shuai Tang, Huanling Lai, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 25
Antimicrobial Bioactivity and GC-MS Analysis of Different Extracts of Corchorus olitorius L Leaves
Rebecca Nakaziba, Sharon Bright Amanya, Duncan C. Sesaazi, et al.
The Scientific World JOURNAL (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top